The sensor employed differential pulse voltammetry (DPV) for detection, exhibiting a linear response in the range of 5–40 ng/mL with an LOD of 3.4 ng/mL, which is lower than the clinical threshold of CEA in cancer patients’ serum (~10 ng/mL). The gene discussed is CEACAM5; the disease is cancer.